You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

07 December 2016

People who inject drugs in the USA – a slow decline in new HIV infections amid worrying emerging trends

Injecting drug use accounted for 9% of all new HIV infections in the USA in 2014 – but new demographic trends among people who inject drugs present new challenges for the HIV response. 

0
21 November 2016

Criminal case against 30 HIV-positive men dropped in the Czech Republic

Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.

0
17 August 2016

World’s largest drug consumption facility opens in Denmark

The world’s largest drug consumption facility has opened in Copenhagen, Denmark, giving people who use drugs a safe place to use illicit substances in a way that will limit harm to themselves, and to those around them.

0
02 August 2016

NHS can provide PrEP – but only if it chooses to

The UK High Court has today ruled that the National Health Service (NHS) England can legally provide the game-changing HIV prevention drug, Truvada, as a pre-exposure prophylaxis (PrEP) to HIV negative people most at risk of HIV – but only if it chooses to.

0
28 July 2016

Hepatitis C among drug users in Europe is high but there is cause for optimism

Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.

0
03 June 2016

Injectable opiate substitution treatment approved by FDA

An injectable version of the opiate substitution treatment (OST) buprenorphine – which is delivered through an implant – has been approved for use in the USA by the Food and Drug Administration (FDA).

0
05 May 2016

USA: HIV incidence declining, but not enough to reach targets

The number of new HIV infections in the USA has fallen by 11% between 2010 and 2015, however the rate of decline falls far short of the goals set in the 2010-2015 National HIV/AIDS Strategy (NHAS).

0
25 February 2016

Major disparities persist in lifetime risk of HIV diagnosis in the US

Centers for Disease Control and Prevention (CDC) in the USA have released a study of lifetime risk of HIV, concluding that if HIV infection rates remain as they are black gay and bisexual men in Ameria have a 1 in 2 risk of being diagnosed in their lifetime and Latino gay men have a risk of 1 in 4.

0
16 February 2016

HIV prevention in adult film industry – testing alone ‘not sufficient’

An adult film actor has been infected with HIV during production in the USA, prompting the US Centers for Disease Control (CDC) to call on the industry to re-evaluate its approach to HIV prevention, as ‘testing alone is not sufficient to prevent occupational HIV transmission’.

0
09 February 2016

Black Americans less likely to remain in HIV care

New research indicates that only 38% of black Americans living with HIV consistently remain in HIV care, compared to 50% for Hispanic/ Latino Americans, and 49% for white Americans. 

0